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ABSTRACT 
 
There is abundant evidence that H2O2 can act as an endothelium-derived hyperpolarizing 
factor in the resistance vasculature. However, whilst scavenging H2O2 can abolish 
endothelial dependent hyperpolarization (EDH) and the associated vascular relaxation in 
some arteries, EDH-dependent vasorelaxation can often be mimicked only by using 
relatively high concentrations of H2O2. We have examined the role of H2O2 in EDH-
dependent vasodilatation by simultaneously measuring vascular diameter and changes in 
endothelial cell (EC) [Ca2+]i during the application of H2O2 or carbachol, which triggers EDH. 
Carbachol (10 µM) induced dilatation of phenylephrine-preconstricted rat cremaster 
arterioles was largely (73%) preserved in the presence of indomethacin (3 µM) and L-NAME 
(300 µM). This residual NO- and prostacyclin-independent dilatation was reduced by 89% 
upon addition of apamin (0.5 µM) and TRAM-34 (10 µM), and by 74% when an extracellular 
ROS scavenging mixture of SOD and catalase (S&C; 100 U.ml-1 each) was present.  S&C also 
reduced the carbachol-induced EC [Ca2+]i increase by 74%. When applied in Ca
2+-free 
external medium, carbachol caused a transient increase in EC [Ca2+]i. This was reduced by 
catalase, and was enhanced when 1 µM H2O2 was present in the bath. H2O2 -induced 
dilatation, which occurred only at concentrations ≥100 µM, was reduced by a blocking 
antibody to TRPM2, which had no effect on carbachol-induced responses. Similarly, 
iberotoxin and Rp-8bromo cGMP reduced the vasodilatation induced by H2O2, but not by 
carbachol. Inhibiting PLC, PLA2 or CYP450 2C9 each greatly reduced the carbachol-induced 
increase in EC [Ca2+]i and vasodilatation, but adding 10 µM H2O2 during PLA2 or CYP450 2C9 
inhibition completely restored both responses.  The nature of the effective ROS species was 
investigated by using Fe2+ chelators to block the formation of ∙OH. A cell permeant chelator 
was able to inhibit EC Ca2+ store release, but cell impermeant chelators reduced both the 
vasodilatation and EC Ca2+ influx, implying that ∙OH  is required for these responses. The 
results indicate that rather than mediating EDH by acting directly on smooth muscle, H2O2 
promotes EDH by acting within EC to enhance Ca2+ release. 
 
Keywords: Endothelium dependent hyperpolarization, arteriole, Ca2+, reactive oxygen 
species, vasodilation, H2O2 
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Abbreviations  
AACOCF3, arachidonyl trifluoromethyl ketone; AUDA, 12-(3-adamantan-1-yl-
ureido)dodecanoic acid; CP85, Na-1-ethylsulfoxide-2-methyl-3-hyroxypyridin-4-one; CP94, 
1,2-diethyl-3-hyroxypyridin-4-one;  CPA, Cyclopiazonic Acid; DFO, Desferrioxamine;  EC, 
endothelial cell;  EDH, endothelial dependent hyperpolarization;  EDHF EDH factor; EDH 
response (EDHR); EETs,  epoxyeicosatrienoic acids; EEZE, 4, 15-epoxyeicosa-5(Z)-enoic acid; 
sEH, epoxide hydrolase;  EGTA, ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-
tetraacetic acid; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; IBTx, 
Iberiotoxin; IL- -1β; IP3R, IP3 receptor; L-NAME, N(G)-nitro-L-arginine methyl 
ester; L-NNA, Nω-Nitro-L-arginine; NO, nitric oxide; ODYA, 17-octadecynoic acid; PE, 
phenylephrine; PGI2, prostacyclin; PKG, protein kinase G; PLA2, phospholipase A2; 
cPLA2,cytoplasmic PLA2; PLC, phospholipase C; PPOH, 2-(2-propynyloxy)-benzenehexanoic 
acid;  PSS, physiological salt solution;  ROS, reactive oxygen species; SERCA, sarcoplasmic 
reticulum Ca2+-ATPase; SOD, superoxide dismutase; S&C; SOD and catalase; VSMC, vascular 
smooth muscle cell. 
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Introduction 
Endothelium-dependent hyperpolarization (EDH) plays an important role in the 
vasodilatation of small arteries and arterioles induced by diverse stimuli including locally 
released factors, blood flow, and low pH [1]. EDH was initially viewed as resulting from the 
release of a diffusible endothelial factor, termed EDHF [2], but is now also thought to 
involve the transmission of endothelial cell hyperpolarization to the underlying vascular 
smooth muscle cells (VSMCs) via myoendothelial gap junctions [3]; the relative importance 
of each mechanism is thought to vary between different arteries/arterioles and also 
depends on the degree of pre-existing vascular excitation [4]. In either case, calcium-
activated potassium channels KCa2.3 and KCa3.1 (SKCa and IKCa respectively) have been shown 
to play a significant part in the EDH response (EDHR).   
 
Pomposiello et al. [5] suggested that H2O2 has a role to play in the EDHR, and a little later it 
was shown that L-NNA- and indomethacin-resistant vasodilatation and hyperpolarization 
elicited by acetylcholine in mouse small mesenteric arteries was attenuated by catalase and 
associated with increased endothelial ROS production [6]. Further evidence that H2O2 acts 
as an EDHF was also reported for dog coronary resistance arteries [7, 8] and human small 
mesenteric [9] and coronary arteries [10]. Liu et al. [11] showed that an endothelium-
denuded segment of human coronary artery dilated when it was perfused by the effluent 
from an upstream endothelium-intact artery subjected to increased shear stress, and that 
this dilatation was attenuated if an H2O2-scavenging column was interposed between the 
donor and recipient arteries. The possibility that H2O2 acts as an EDHF is also consistent with 
observations by other groups that application of exogenous H2O2 opens VSMC BKCa channels 
[12], hyperpolarizes VSMCs [13] and relaxes a variety of vascular preparations [10,14, 
15,16]. The evidence for H2O2 as the primary contributor to the EDHR evoked by bradykinin 
is also compelling for cerebral arterioles, in which it appears that cyclooxygenase-dependent 
production of H2O2 causes vasodilation by acting on BKCa channels [16, 17]. Most 
convincingly, Eaton and colleagues [18] showed that a mouse with knocked-in redox-
insensitive protein kinase G were hypertensive and had mesenteric vessels that were less 
sensitive to applied H2O2. However, one concern with many of the studies in which the 
effect of exogenous H2O2 was examined is that the EC50 for H2O2 – induced vasodilatation of 
endothelium-denuded arteries was above 10 M (e.g. 10, 14, 16] Notably, Liu et al. [11] 
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reported that whereas the vasodilating effluent they collected from endothelium-intact 
perfused human coronary arteries contained 0.6 M H2O2, vasodilatation of endothelium-
denuded arteries by exogenous H2O2 was negligible at a concentration of 10 M.  
 
Intriguingly, although H2O2 dilated endothelium-intact human submucosal intestinal 
microvessels, it caused constriction following endothelial denudation, a finding which led to 
the suggestion that H2O2 promotes the release of a separate EDHF instead of itself acting as 
an EDHF [15].  It was subsequently shown by Griffith and co-workers that the application of 
100 M H2O2, or the oxidizing agent thimerosal, to rabbit aortic valve endothelial cells (EC) 
enhanced intracellular Ca2+ release evoked by the SERCA inhibitor cyclopiazonic acid (CPA). 
Moreover, CPA-induced vasodilatation of rabbit ileac arteries was attenuated by application 
of catalase. They proposed that H2O2 could potentiate EDH-dependent vasodilatation by 
increasing IP3 - dependent Ca
2+ release [19]. Soon afterwards this group demonstrated that 
applying H2O2 concentrations of 10-30 M also potentiated the EDH-associated vasodilation 
caused by acetylcholine in rabbit ileac arteries [20].  
 
These studies suggest strongly that H2O2 acts to enhance rather than mediate the EDHR, and 
pose a number of important questions which are currently unanswered. As the ability of 
H2O2 to facilitate the EDHR has not been compared to its direct vasodilator effects in any 
single preparation, it remains unknown which of these effects are likely to be of 
predominant importance during the EDHR. Also, the pathways leading to H2O2 production 
within EC which would facilitate increases in EC [Ca2+]i during the EDH response have not 
been defined. In addition, it is not clear whether physiological stimuli which have been 
shown to increase ROS production in EC lead to increases in the EDHR as would be predicted 
by this mechanism.  
 
We have investigated these issues in arterioles in the intact rat cremaster circulation, as this 
preparation exhibits robust, sustained and consistent dilatations to both carbachol and 
H2O2, and permits endothelial Ca
2+ concentration changes to be measured simultaneously. 
We characterized the effects of anti-oxidants and blockers of potential ROS-producing 
pathways on increases in EC [Ca2+]i and the associated NO- and PGI2-independent 
vasodilation evoked by the muscarinic receptor agonist carbachol. In addition, we carried 
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out a comparison of the effects of carbachol and exogenously applied H2O2 in order to 
determine whether H2O2 might be acting as an EDHF. We also assessed whether EDH and 
ROS contribute to the vasodilatation induced by the inflammatory mediator cytokine IL-
1 Our results show that under basal conditions, endogenous ROS production involving 
CYP92C, phospholipase A2 and hydroxyl radical greatly facilitates EC Ca
2+ release and EDH-
associated vasodilation. A brief pre-incubation with IL-1  further enhances the responses to 
carbachol. Although H2O2 also dilated these arterioles directly, it only did so at high 
concentrations, and via mechanisms which differ markedly from those evoked by carbachol.   
  
Methods 
This study conforms with the Guide for the Care and Use of Laboratory Animals published by 
the US National Institutes of Health (NIH Publication No. 85–23, revised 1996) and is in 
accordance with UK Home Office regulations (Animals Scientific Procedures) Act, 1986. 
 
4-6 week old male Wistar rats (Charles River, UK) weighing 80-100g were killed by exposure 
to an increasing concentration of CO2 followed by cervical dislocation. A midline incision was 
made along the abdomen and the skin and muscle layer were retracted to expose the 
underlying organs. The inferior vena cava was tied off above the bifurcation into the 
common iliac veins and below that an incision was made to allow blood to drain from the 
lower extremities. A 0.61mm fine bore polythene cannula was inserted down to the 
bifurcation into the common iliac arteries via the abdominal aorta and secured with thread. 
The left common iliac and the right femoral and internal iliac arteries were ligated to ensure 
that perfusion was only to the right external iliac artery supplying the cremaster artery and 
the cremaster muscle. This was then perfused through the cannula with a stabilizing 
solution (10 Mg2+, 110 NaCl, 8 KCl, 10 HEPES, 1 CaCl2+ all mM) containing heparin (30 U/ml) 
with isoproterenol 10 µM buffered to pH 7.0 ± 0.05 for 10 minutes to remove all blood.  
 
The cremaster muscle was prepared by a midline incision along the scrotum to expose the 
right testes. Skin and connective tissue were carefully removed from the underlying 
cremaster muscle, which was then cut longitudinally along the anterior surface from the 
apex to the inguinal canal while keeping the vascular supply and drainage at the base intact. 
The testis was separated from the cremaster muscle and was pulled through the inguinal 
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canal so as not to obstruct the preparation. The muscle was spread out flat onto a clear 
Sylgard disc using forceps and secured using micro- histology pins, and the cardioplegic 
solution perfusing the circulation was then replaced for the duration of the experiment with 
PSS containing 0.1% albumin delivered by a gravity controlled reservoir. The preparation 
was moved to the stage of a Leitz Intravital microscope equipped with Orthoplan optics, and 
was superfused with PSS at 37°C at a flow rate of 2.5 ml/min. PSS contained the Na+ channel 
blocker lidocaine (20 mg.l-1) to block neural activity and keep the cremaster muscle from 
contracting.  
 
Following a 30 min equilibration period an appropriate 2nd order arteriole (diameter 50-100 
µm) was constricted by superfusion with 30 µM phenylephrine (PE) in combination with 300 
µM N(G)-nitro-L-arginine methyl (L-NAME) and 3 µM indomethacin to inhibit NO and PGI2 
mediated vasodilatation. Constriction was maintained for 20 min to ensure its stability, and 
the muscarinic receptor agonist carbachol (10 µM) was then added for 2 min to the 
superfusate to elicit vasodilation. Arterioles were used for experiments only if a 
vasodilatation of >50% (measured as described below) was observed. 
 
During the experiments PE, L-NAME and indomethacin were present throughout. Drugs 
used to characterize the EDHR were added to the superfusate for 2-20 minutes before, and 
during, the application of carbachol.  In experiments examining the effect of IL-1 the 
preparation was superfused for 15 minutes with PSS containing the cytokine at a 
concentration of 100 pM. IL-1  was then washed out briefly and carbachol was applied. 
 
Diameter measurements and EC [Ca2+]i measurements 
Arterioles were visualized with a x40 water-immersion objective lens (allowing diameter 
measurements to be taken to an accuracy of 1 µm) and were perfused for 1 hour at room 
temperature with PSS containing 10μM Fura-PE 3 AM, 1% DMSO, 0.02% pluronic acid and 
1% albumin in order to selectively load the endothelium with furaPE3. The preparation was 
then perfused with PSS and the superfusate temperature was raised to 37°C. Following a 15 
minute equilibration and washout period, arterioles were illuminated alternately at 360 and 
380 nm at 1 Hz using a filter wheel (Cairn Research Ltd, UK) and images were recorded at 
>530 nm using an Intensified ISIS camera (Photonic Sciences, UK). Images were analyzed 
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using ImageHopper (Samsara Research: Dorking, Surrey, UK) software. Diameter was 
measured using the inner margin of the 380nm signal. A semi-quantitative calculation of the 
endothelial Ca2+ concentration (hereafter termed EC [Ca2+]i) was made by subtracting the 
average background (adjacent to the arterioles) signal from the image, normalizing the 
signals from the vessel during the 360 and 380 nm excitation intervals, and calculating the 
360/380 ratio at each pixel.  PE had no effect on the 360/380 ratio, which indicates that 
FuraPE3 was confined to the endothelium.  Furthermore, carbachol and TRAM-34 co-
applied with apamin produced changes in the 360/380 ratio that would be expected from 
selective FuraPE3 endothelium loading. 
 
Drugs and solutions.  
PSS contained (in mM) 124 NaCl, 5 KCl, 22 NaHCO3, 5 glucose, 2 MgSO4, 0.125 NaH2PO4, 2 
CaCl2, and was gassed with 5% CO2 - balance air to maintain the pH at 7.40. St. Thomas’ 
cardioplegic (stabilizing) solution contained (in mM) 110 NaCl, 7.9 KCl 34 MgCl2, 1 CaCl2, 11 
HEPES, 0.01 isoprenaline and 0.01 ascorbic acid as an antioxidant. Drugs were made up 
freshly each day or made from stock solutions stored at -20°C with final concentrations 
made up in PSS. All drugs were purchased from Sigma Aldrich UK, other than: TRPM2 
antibody (Cambridge Bioscience), arachidonyl trifluoromethyl ketone (AACOCF3: Merck 
Chemicals), heparin (AAH Hospital Services), TRAM-34 (Tocris Bioscience) and lidocaine 
(Braun Medical). CP94 (1,2-diethyl-3-hyroxypyridin-4-one) and CP85 (Na-1-ethylsulfoxide-2-
methyl-3-hyroxypyridin-4-one) were kind gifts from Professor R.C. Hider, King’s College 
London. 
 
Presentation of data and statistical analysis 
Endothelial cell [Ca2+]i is represented as the peak % increase in the Fura-PE3 360/380 ratio 
from the baseline. Vasodilatation is represented as the maximum % reversal of PE-induced 
constriction. Carbachol responses were recorded under control conditions and then again 
following an intervention (e.g. application of an inhibitor), so that each arteriole acted as its 
own control and results could be analyzed using a two-tailed paired t-test. It was possible to 
do so because the responses evoked by carbachol were stable when repeated (rise in Fura-
PE3 360/380 ratio and vasodilation of 20.5 ± 2.4% and 75.3 ± 3.5%, respectively, during first 
application of carbachol; rise in Fura-PE3 360/380 ratio and vasodilation of 22.1 ± 2.6% and 
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72.5 ± 3.2 %, respectively during second response to carbachol applied 15 minutes later, n = 
21, ns). Bar charts represent mean ± S.E.M values. 
 
Results 
Role of ROS in EDH-associated carbachol-induced vasodilation of rat cremaster arterioles 
PE (30 µM) application to cremaster resulted in a sustained constriction (36 ± 3%, n=5), and 
subsequent carbachol (10 µM) application resulted in a well-maintained vasodilatation, 
amounting to a 72.6 ± 2.4% reversal of the constriction (n = 55). Fig 1A shows an example of 
this, and Figs 1B & 1C illustrate the results of 4 paired experiments in which the 
vasodilatation of arterioles and their accompanying venules was measured. The 
vasodilatation was reduced somewhat in the presence of L-NAME (300 µM) and 
indomethacin (3 µM) (Fig. 1B). Interestingly, this was less in the venules than the arterioles 
(arteriolar vasodilatation reduction 30 ± 1.3%, venular reduction 19 ± 1.7%; p<0.001 t test, 8 
paired vessels).  Addition of apamin (0.5 µM) with Tram-34 (10 µM) to block endothelial SKCa 
(KCa2.3) and IKCa (KCa3.2) channels respectively, resulted in a much greater reduction: a 
further 62 ± 3.3% in arterioles and 70 ± 1.3% in venules (p<0.05  t test, 4 paired vessels).  
When a free radical scavenging mixture of superoxide dismutase (SOD) and catalase (S&C; 
both 100 U/ml) was used instead of Tram-34 and apamin (Fig. 1C) there was a similar 
reduction in carbachol-induced vasodilatation (arterioles 49 ± 5.3% and venules 62 ± 5.2% 4 
paired vessels, ns). 
 
The carbachol-induced arteriolar vasodilatation was accompanied by a sustained increase in 
EC [Ca2+]i which was not affected by the presence of L-NAME and indomethacin (24.5 ± 5.4 
vs 24.1 ± 4.6% increase, n=4, ns). All experiments described hereafter were carried out in 
the presence of L-NAME and indomethacin in order to allow the EDH-associated 
vasodilatation to be recorded in isolation. 
   
As shown in Figure 2, both the rise in EC [Ca2+]i and the vasodilatation induced by carbachol 
were greatly diminished in the presence of S&C. Figure 2A illustrates images of the 360/380 
fluorescence emission ratio in a Fura PE3 loaded cremaster arteriole in the presence of PE 
(upper left), and after 10 M carbachol was applied (upper right). The arteriole was 
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subsequently washed with PSS, superfused with PE in the presence of S&C (lower left), and 
again exposed to carbachol (lower right). The effect of S&C on the carbachol-induced  
 
  
Figure 1 Properties of the carbachol-induced EDHR in rat cremaster microvasculature. (A) 
Representative experiment illustrating  the constricting effect of applying phenylephrine (30 
µM) and the subsequent sustained dilating action of carbachol (10 µM). (B) Paired 
experiments in which the dilatation induced by carbachol was reduced by co-applying L-
NAME (300 µM) with indomethacin (3 µM), and subsequent apamin (0.5 µM) with Tram-34 
(10 µM) or (C) a ROS scavenging mixture of superoxide dismutase and catalase (100 U/ml 
each). Analysis of variance followed by Tukey’s multiple comparison test *** p < 0.001, ** p 
< 0.01. 
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increase in EC [Ca2+]i was sustained, as shown in Figure 2B. Figure 2C shows that in six paired 
vessels that S&C application reduced the carbachol-induced vasodilatation (left) and 
increase in EC [Ca2+]i  (right) on each occasion.  
 
 
Figure 2. Carbachol-induced EDHF response is ROS dependent (A) Example of the effect of 
S&C (both 100 U/ml) on the carbachol-mediated rise in EC [Ca2+]i and vasodilatation in an 
arteriole, and (B) the time course of the carbachol-induced rise in the 360/380nm ratio and 
its attenuation by S&C. (C) S&C reduces the vasodilatation and (D) the endothelial [Ca2+]i 
responses to carbachol (n = 6) paired t test, *** p < 0.001, ** p < 0.01). 
 
Carbachol stimulates muscarinic M1 and M2 receptors which will result in activating 
phospholipase C and phospholipase A2 respectively. Inhibiting PLC with 3 M U73122 
resulted in much reduced vasodilatation and Ca2+ responses (to 11.6 ± 1.1% and 13.8 ± 
1.8%, respectively), whereas the inactive U73122 analogue U73343 (3 M) had no effect on 
either response (Fig. 3A). This suggests that store release of Ca2+ is a key requirement for 
the EDH response.  Similarly PLA2 inhibition by 3 M AACOCF3 also reduced the 
vasodilatation and Ca2+ responses (Fig. 3B), but to a lesser extent.  The arachidonic acid 
released by PLA2 can interact with a number of enzymes to generate reactive oxygen species 
(ROS), notably cyclooxygenases, lipoxygenases, xanthine oxidase, and cytochrome P450 
isoforms. We used a number of inhibitors to investigate possible sources, namely allopurinol 
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(xanthine oxidase), nordihydroguaiaretic acid (lipoxygenase), and sulfaphenazole 
(cytochrome P450), while indomethacin was always present to block cyclooxygenase. Of 
these only sulfaphenazole, a selective cytochrome P450 2C9 inhibitor [21] reduced the 
responses to carbachol (Fig. 3C). The less specific inhibitors 2-(2-propynyloxy)-
benzenehexanoic acid (PPOH) and 17-octadecynoc acid (ODYA) were equally effective 
(supplementary Fig. 1).  These effects were not due to a reduction in the production of EETs, 
since neither the EETs antagonist 4, 15-epoxyeicosa-5(Z)-enoic acid (EEZE) nor the soluble 
epoxide hydrolase (sEH) blocker 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA) had 
any effect on the carbachol responses (Supplementary Fig. 2B). It is interesting to note that 
the reduction in vasodilatation and the Ca2+ response with AACOCF3 and sulfaphenazole was 
significantly less than with PLC inhibition (AACOCF3 vasodilatation 25.6 ± 6.9% and EC [Ca
2+]i 
24.9 ± 4.1%; sulfaphenazole vasodilatation 30.1 ± 4.4% and EC [Ca2+]i 37.2 ± 3.7%) (Anova: 
EC [Ca2+]i  P< 0.005; vasodilatation P< 0.05).  
 
H2O2 assists release of Ca
2+ from intracellular stores 
Carbachol-induced release of intracellular Ca2+ by the endothelium was recorded in 
arterioles perfused and superfused with Ca2+ free PSS containing 0.2 mM EGTA in order to 
prevent Ca2+ influx. Under these conditions carbachol caused a transient increase in 
EC [Ca2+]i, which was significantly attenuated by S&C (Fig. 4A and 4B). Further experiments 
revealed that the increase in EC [Ca2+]i was similarly reduced by catalase alone, but was 
unaffected by SOD (Fig. 4B).  Since reducing H2O2 levels suppressed the carbachol-induced 
increase in EC [Ca2+]i and the associated vasodilation, it might be predicted that increasing 
H2O2 levels should correspondingly facilitate the response to carbachol. As depicted in 
Figure 4C, application of 1 M exogenous H2O2 significantly increased the transient 
carbachol-induced rise in EC [Ca2+]i in Ca
2+-free PSS.  The role of cytochrome P450 2C9 in 
assisting Ca2+ release was confirmed by the inhibitory action of sulfaphenazole (Fig. 4D) on 
this response. 
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Figure 3.  Paths by which carbachol induces EDHF response.  (A) The PLC inhibitor U73122, 
but not the structurally similar U73343 (both 3 µM), very much reduced the [Ca2+]i (from 
22.3 ± 3.2%) and the vasodilatation (from 75.3 ± 2.7 to 10.4 ± 1.9%) responses to carbachol 
(10 µM). (B) The PLA2 inhibitor AACOCF3 (3 µM) and (C) the cytochrome P450 2C9 inhibitor 
sulfaphenazole (10 µM) also reduced the [Ca2+]i and vasodilatation responses. 5 vessels in 5 
animals for each data set; paired t tests *** p < 0.001. The reduction with U73122 was 
greater than with either AACOCF3 or sulfaphenazole (see text). 
 
14 
 
 
Figure 4. Role of ROS on endothelial Ca2+ release using Ca2+-free Krebs buffer 
A) Example of the effect of S&C (both 100 U/ml) on the carbachol-induced rise in EC [Ca2+]i. 
B) Average effect of SOD and catalase applied in combination or independently on the peak 
carbachol-induced transient rise in EC [Ca2+]i. C) Effect of  1µM H2O2 and D) of 
sulfaphenazole (10 µM) on the carbachol induced increase in EC [Ca2+]i. (n = 5 for B-D, 
paired t test **p<0.01, ***p<0.001). 
 
 
The results depicted in Figs. 3 & 4 are consistent with the concept that arachidonic acid 
released by PLA2 is metabolized by CYP2C9 to produce ROS, which then potentiate 
carbachol-induced Ca2+ release. To further test this idea we added H2O2 (10µM, a 
concentration that produced no vasodilatation on its own (see next section and Figure 6A) 
to preparations where either PLA2 or CYP2C9 were blocked with AACOOCF3 or 
sulphaphenazole, respectively. In both cases H2O2 fully restored vasodilatation and Ca
2+ 
responses (see Fig. 5A & 5B). 
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Figure 5. Reversal of the effects of ROS-generating enzyme inhibition by H2O2.  
10 M H2O2, which alone had no effect on vessel diameter, was applied to arterioles where 
(A) AACOCF3 (3 µM) or (B) sulphaphenazole (10 µM) had reduced the carbachol induced 
vasodilatation (left) and rise in EC [Ca2+]i (right). In both cases, H2O2 fully reversed the effects 
of the inhibitors. (5 vessels from 5 animals; paired t test *** p<0.001).  
 
Properties of the response to H2O2 applied exogenously on its own 
Application of H2O2 to PE-preconstricted arterioles caused a steeply concentration-
dependent vasodilatation, with an apparent threshold at ~30 M and maximum at 100 M 
H2O2 (Fig. 6A). When evaluated in a larger number of arteries, vasodilatation at 100 M H2O2 
was similar to but slightly smaller than that induced by 10 M carbachol (73.7 ± 1.4% vs 80.8 
± 1.4%, n = 22, p<0.05), and was accompanied by a rise in EC [Ca2+]i  which was also 
somewhat smaller than that caused by carbachol (22.6 ± 1.4% vs 26.0 ± 1.4%, n = 22, p 
<0.05).  
 
The possibility that the exogenously applied H2O2 resulted in opening the TRPM2 channel 
was tested by using a blocking antibody that had been shown to block H2O2-induced Ca
2+ 
influx into cultured endothelial cells (Hecquet et al., 2008).  It is interesting to note that the 
EC50 for activation of this channel by H2O2 (~60µM), is consistent with the dose-response 
relationship we found (Fig. 6A). Application of the TRPM2 antibody reduced both the H2O2-
induced rise in EC [Ca2+]i and vasodilatation, but left these responses to carbachol 
unaffected (Fig. 6B).  
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Figure 6. Effects of exogenous hydrogen peroxide (A) Concentration dependency of H2O2 
induced vasodilation with 300 µM L-NAME and 10 µM indomethacin present (n=4). (B) Pre-
incubation with TRPM2 antibody (5 µg.ml-1) reduced the vasodilatation and Ca2+ responses 
to exogenous H2O2, but not to carbachol. (C) H2O2 caused vasodilatation that was inhibited 
by Rp-8bromo cGMP (100 µM), IBTx (100 nM), but these had no effect on EC [Ca2+]i. (D) The 
combination of TRAM34 (10 µM) and apamin (0.5 µM) reduced the vasodilatation and Ca2+ 
responses. In contrast, neither Rp-8bromo cGMP nor IBTx had any influence on the 
carbachol, responses (E & F). n = 5 – 9 vessels, each from separate animals. 
 
Although both 100 M H2O2 and carbachol caused roughly equivalent effects on EC [Ca
2+]i 
and vascular diameter, they apparently did so through different mechanisms. As shown in 
Fig. 6C & 6D, the vasodilatation elicited by H2O2 was strongly suppressed by the protein 
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kinase G blocker Rp-8-Br-cyclic GMP (100 M) and the BKCa channel inhibitor IBTx, (100nM), 
and was to a smaller extent also sensitive to the combination of apamin (500 nM) and 
TRAM-34 (10 µM). Conversely, Rp 8Br-cyclic GMP and IBTx had no effect on the H2O2-
induced rise in EC [Ca2+]i, which was strongly supressed by the TRPM2 antibody and TRAM-
34 + apamin. Inhibiting PKG and the BKCa channel, however, had no effect on the carbachol-
mediated responses (Fig. 6E & 6F).  TRAM-34 & apamin reduced vasodilatation mediated by 
H2O2 (-37 ± 2.8%), which was significantly less than that mediated by carbachol (-82 ± 2.8%; 
P < 0.001) 
In additional experiments we found that CP94, which inhibited carbachol induced 
vasodilation (see below), had no affect on dilatation to H2O2 (78.0 ± 2.5 % in H2O2 vs 77.0 ± 
2.1 % in H2O2 with CP94, n = 5, ns). H2O2-induced vasodilation was also unaffected by 
AACOCF3 (69.8 ± 1.8 % in H2O2 vs 68.7 ± 1.8 % in H2O2 + AACOCF3, n = 5, ns). 
 
The nature of the ROS involved in carbachol-mediated effects  
Desferrioxamine and the hydroxypyridinones CP94 and CP85 are selective iron chelators, 
but differ in that CP94 is cell permeable while the other two are not (Rai et al., 1998). As 
shown in Fig. 7A, CP94 (100 M) significantly reduced the transient carbachol-induced rise 
in EC [Ca2+]i in Ca
2+ free PSS,  while neither desferrioxamine nor CP85 (100 M)  had any 
effect on this response. This supports the view that ∙OH, rather than H2O2 itself, is the 
radical responsible for Ca2+ release from stores. 
 
In the presence of extracellular Ca2+, all three iron chelators inhibited the carbachol-induced 
rise in endothelial [Ca2+]i (Fig. 7B) and reduced the accompanying vasodilation (Fig. 7C). 
Notably, none of these substances had any effect on the PE induced contraction (not 
shown). 
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Figure 7. Effects of iron chelation on carbachol responses. Effects of the cell permeable 
CP94 and the cell impermeable desferrioxamine, CP85 (each 100 µM) iron chelators on 
carbachol responses. (A) In Ca2+-free PSS the induced rise in the EC [Ca2+]i is reduced only 
with CP94. (B) When Ca2+ was included in the medium all the chelators reduced the [Ca2+]i 
and the (C) vasodilatation responses. (5 vessels from 5 animals; paired t test *p<0.05, ** 
p<0.01). 
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IL-1β causes ROS-dependent vasodilatation and elevation of EC [Ca2+]i 
We have previously shown that a brief application of a low concentration of interleukin-1β 
(30pM for 10 min) results in endothelial ROS generation via NADPH oxidase [23], and that 
this is prevented by co-application with a low concentration of apocynin (1µM; [24]).  As 
shown in Fig. 8, a 15 min pre-incubation of the preparation with IL-1  (30 pM), followed by 
a subsequent brief wash to remove the cytokine, resulted in increased EC [Ca2+]i and 
vasodilatation responses that were much reduced by scavenging ROS.  Furthermore, this 
potentiating effect was abolished when apocynin (1 μM) was co-applied and washed off 
with IL-1β. NADPH oxidase assembly requires phosphorylation of p47phox by protein kinase C 
[25], and when the broad spectrum PKC inhibitor Ro31-8220 (3 M) was applied with IL-1β, 
the potentiation was also abolished.  Neither apocynin nor Ro31-8220 affected the response 
to carbachol in the absence of IL-1β (Supplementary Fig. 3). 
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Figure 8. Evidence that IL-1β increases the response to carbachol via NADPH oxidase. 
IL-1β (30 pM) applied for 15 min. resulted in increased (A) vasodilatation and (B) EC  [Ca2+]I 
responses. Co-application with either apocynin (1µM) or Ro31-8220 (3µM) blocked the 
increases, while a radical scavenging mixture of SOD and catalase (100U/ml each) reduced 
the total responses.  (5 vessels from 5 animals; paired t tests ** p<0.01; *** p<0.001; IL-1β 
vs IL-1β +apocynin # unpaired ‘t’ test p<0.05 
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Discussion 
 
The key finding of this study is that whilst the EDHR triggered by carbachol is largely ROS-
dependent, it does not involve an effect on VSMCs of H2O2 released by the endothelium. 
Instead, the results demonstrate that ROS generated by endothelial cytochrome P450 2C9 
make a crucial contribution to the EDHR triggered by muscarinic receptor stimulation in rat 
cremaster arterioles.  They do this by acting on the endothelium to potentiate Ca2+ release 
from intracellular stores and enhancing Ca2+ entry across the plasma membrane rather than 
by acting directly as an EDHF.  There have been previous indications that this is an important 
mechanism: thus catalase suppresses cyclopiazonic acid (CPA) induced Ca2+ release in rabbit 
aortic valve endothelium, as well as EDH-dependent, acetylcholine-induced vasodilatation 
of rabbit iliac arteries. Furthermore, raising the H2O2 concentration facilitates acetylcholine 
and CPA induced vasodilatation [19,20]. CPA induced Ca2+ release was also shown to be 
potentiated by the IP3R sensitising agent thimerosal, which implies that H2O2 may be 
exerting a similar sensitising effect, as described for the IP3R in human aortic endothelial 
cells [26]. Based on these and related findings, the late Tudor Griffith and colleagues 
proposed that H2O2 was acting to promote the EDH response by facilitating IP3R-mediated 
endothelial Ca2+ release and thereby raising [Ca2+]I [19].   
 
Phospholipase C, Phospholipase A2 and CYP450 2C9 
Carbachol activates both M1 the M2 receptors, which are linked to phospholipase C and 
phospholipase A2 respectively. The present findings indicate that both are required for the 
full EDHR.  We showed that blocking PLC with U73122 inhibits increases in both endothelial 
[Ca2+]i and vasodilatation (see Fig 3A), which is consistent with the finding that many 
agonists evoke vasodilatation and [Ca2+]i increases that are dependent on endothelial PLC 
activation [27]. Our results are consistent with those of Fukao et al who showed that PLC is 
crucial for the EDHR in rat mesenteric arteries, implying that IP3R-mediated Ca
2+ release is 
pivotal for both events [28].   
 
We have also shown that a pathway involving both cPLA2 and CYP2C9 is the source for ROS 
in the carbachol-induced EDHR in these arterioles. Our results (Fig. 3B), demonstrate that 
the cPLA2 inhibitor AACOCF3 suppressed the carbachol-induced EDHR. A role for cPLA2 in 
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EDH has previously been demonstrated in some [29, 30, 31] but not all arteries [32]. 
Although this could reflect a role for EETs generated as CYP450 metabolises arachidonic acid 
produced by cPLA2, it may also depend upon ROS produced the same pathway. This 
possibility was investigated in porcine coronary arteries, but it was found that this did not 
apply to the EDHR triggered by bradykinin [5]. In contrast, increases in endothelial 
permeability evoked by bradykinin in cerebral venular capillaries were found to depend on 
ROS generated when arachidonic acid produced by cPLA2 is metabolised by cyclooxygenase 
and lipoxygenase [33].  
 
CYP450 has been thought to be involved in the EDH response by virtue of its production of 
EETs, which were initially proposed to act via opening BKCa channels in vascular smooth 
muscle cells (e.g. 34, 35). More recently however, EETs generated by CYP450 2C9 were 
shown to act within endothelial cells by increasing [Ca2+]i by recruiting TRP channels to the 
plasmalemma [21, 36].   
 
On the other hand, CYP450 enzymes are also a source of ROS [37], and furthermore, basal 
ROS production by endothelial cells is dependent on the CYP450 2C9 isoform, as shown by 
using antisense oligonucleotides [35] and sulfaphenazole [37], both of which suppress EDH.  
Nevertheless, the possibility that CYP450 2C9 might promote EDH via ROS generation, as 
indicated by the results depicted in Fig. 3C, seems not to have been previously considered. 
Sulfaphenazole strongly suppressed carbachol-induced Ca2+ release, as well as the rise in EC 
[Ca2+]i and the associated vasodilatation in normal Ca
2+ solution, and neither the EETs 
antagonist EEZE nor AUDA had any effect on the carbachol responses (Supplementary Fig. 
2B). Moreover, although in accordance with previous reports (e.g. 39) we observed that 
BKCa channel blockade with IBTx inhibited the vasodilatation caused by application of 
exogenous 11, 12 EET, IBTx had no effect on the carbachol-induced vasodilatation 
(Supplementary Fig. 2A).  
 
Exogenously applied H2O2 
Whereas the experiments with anti-oxidants and blockers of endothelial ROS-producing 
pathways indicate that H2O2 acts by potentiating the carbachol-induced EC [Ca
2+] increase, 
they do not exclude an additional direct effect of H2O2 on arteriolar vascular smooth muscle 
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during EDH. We therefore carried out a systematic comparison of the properties of the 
vasodilator responses to H2O2 and carbachol-induced EDH. The dose response relationship 
between H2O2 and vasodilatation (Fig. 6A) is consistent with most others that do not show 
significant vasodilatation below 50 µM (e.g. 6, 11). The vasodilatation caused by H2O2 was 
strongly attenuated by Rp-8Br-cGMP and IBTx (see Fig. 6C). Neither of these blockers had 
any effect on the H2O2 induced rise in endothelial [Ca
2+]i (see Fig. 6D), consistent with the 
concept that H2O2 evokes vasodilatation principally via vascular smooth muscle cells by 
causing direct oxidation-induced stimulation of G kinase [18], this leading to cGMP-
mediated opening of BKCa channels [40]. In contrast, responses to carbachol were 
insensitive to these agents, implying that any release of H2O2 on its own by the endothelium 
was too small to activate this pathway. It appears, however, that the rise in endothelial 
[Ca2+]i triggered by 100 M H2O2 also makes a significant contribution to the vasodilatation, 
since the combination of TRAM-34 and apamin reduced vasodilation to H2O2. Moreover, a 
TRPM2 antibody previously shown to block H2O2-induced rises in [Ca
2+]i  associated with 
activation of these channels in cultured EC greatly suppressed the H2O2-induced rise in EC 
[Ca2+]i and reduced the accompanying vasodilatation [22].  These results suggest that the 
endothelium-dependent component of the vasodilatation to 100 M H2O2 in these 
arterioles was largely caused by the opening of EC TRPM2 channels, leading to a rise in EC 
[Ca2+]i and a consequent EDHR. This would be expected to open endothelial KCa channels, 
accounting for the small inhibition of the H2O2 induced rise in endothelial [Ca
2+]i caused by 
TRAM-34 + apamin (Fig. 6D, 6F). The observation that the TRPM2 antibody had no effect on 
either the rise in endothelial [Ca2+]i or the vasodilatation induced by carbachol (Fig. 5B) 
further highlights the difference between the pathways by which carbachol and H2O2 
regulate endothelial [Ca2+]i.  
 
It has been argued that relatively high exogenously applied H2O2 does not accurately reflect 
the true intracellular H2O2 due to the effects of peroxidases and a hypothesized barrier to 
H2O2 entry across the plasmalemma [41]. On the other hand, H2O2 has been shown to have 
a high permeability coefficient (1.6x10-3cm.s-1) across the EC membrane [42]. Furthermore, 
we found that the application of just 1 µM H2O2 resulted in a significant increase in 
carbachol-induced Ca2+ release from intracellular stores (see Fig. 4C).  Notably, studies have 
shown that H2O2 at concentrations ≤100 M does not itself cause EC Ca
2+ release in the 
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absence of a co-stimulus. Hu et al., [26] measured the content of the Ca2+ stores in 
permeabilized cultured human aortic endothelial cells (HAEC) using Mag-indo, and found 
that this was not affected by 100 M H2O2, although H2O2 at concentrations above 3 M 
sensitized these cells to IP3-induced Ca
2+ release and 10 M H2O2 promoted histamine-
mediated Ca2+ release in intact HAEC [43]. Similarly it was found that 100mM H2O2 had no 
effect on EC Ca2+ store content, measured using Mag fluo-4, in intact rabbit aortic valve 
endothelium [19].  
 
Similarly, the effects of inhibiting either PLA2 with AACOCF3, or CYP450 2C9 with 
sulfaphenazole were completely reversed by adding H2O2 (10 M), a concentration which on 
its own had no effect (see Fig. 5A & 5B).  Thus, it is clear that the suppression of the 
carbachol-induced EDHR by sulfaphenazole is best explained by a decrease in endothelial 
H2O2 rather than the inhibition of EET release it causes. This effect would explain the finding 
that the EDH-dependent vasodilatation to acetylcholine in guinea-pig coronary arteries was 
antagonised by CYP450 blockers but not IBTx [39], as well as the observation that 
sulfaphenazole-induced attenuation of the EDHR triggered by acetylcholine and bradykinin 
in the human forearm microcirculation was prevented by co-administration of the anti-
oxidant ascorbate [44]. 
 
These findings indicate that ROS produced when CYP 450 2C9 metabolises arachidonic acid 
generated by cPLA2 are responsible for an increase in Ca
2+ release by the IP3R. There is 
evidence [45] that H2O2 is able to sensitize the IP3R to various stimuli in cultured endothelial 
cells. This view is supported to a certain extent by our finding that inhibiting PLC produced a 
significantly greater reduction in the response to carbachol than inhibiting elements of the 
ROS generating pathway (see Fig. 3). 
 
 
Reactive oxygen species mediated signalling  
It is clear that H2O2 generated from the interaction between arachidonic acid and 
CYP 450 2C9 is important for potentiating the release of Ca2+ from stores, since catalase 
alone, rather that superoxide dismutase reduces effects of carbachol.  
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The question whether the Fenton reaction is required for H2O2 to have its effects was 
addressed by using Fe2+ chelators. The involvement of hydroxyl radical in endothelium-
dependent vasodilation was first proposed as a consequence of finding that desferrioxamine 
(DFO) inhibited bradykinin-induced vasodilatation of mouse cerebral arterioles [46].  Few 
subsequent studies have addressed this issue, however, and the limited amount of 
information available on the effects of iron chelation on the EDH as such indicates that 
hydroxyl radical is not involved [10, 30]. Nonetheless, in light of reports that DFO attenuated 
arachidonate-induced vasodilatation and permeability increases in rat cerebral arterioles 
[17, 47], and of our observation that blocking cPLA2 suppressed the responses to carbachol 
in cremaster arterioles, we examined whether these were also affected by DFO and the iron 
chelating 3-hydroxypyridin-4-ones CP94 and CP85. These have little direct radical scavenging 
ability [48], moreover a variety of 3-hydroxypyridin-4-ones of varying membrane 
permeability have been synthesised which allowed us to compare the effects of high (CP94) 
and low (CP85) cell-permeability analogues [49].  
 
If hydroxyl radical rather than H2O2 is sensitising the IP3R, it would be predicted that CP94 
and DFO but not CP85 should inhibit carbachol-induced Ca2+ release, since hydroxyl radical, 
which immediately reacts with other molecules in its vicinity as it is formed, is unlikely to 
cross the cell membrane [50]. This is what we observed. Although the enormous reactivity 
of hydroxyl radical would appear to prevent it from mediating signal transduction, as this 
would require spatially discrete and reversible interactions, there are mechanisms by which 
this could occur. For example, hydroxyl anion is largely scavenged by ascorbate to yield 
dehydroascorbate (see 50), which has been proposed to be transported into the lumen of 
the ER where it acts to promote the oxidation of protein thiols [51]. This might be of 
particular relevance to Ca2+ release. Notably, it ws shown that treatment of aortic EC with 
H2O2 leads to glutathionylation of the IP3R1 and an increase in its sensitivity to [Ca
2+] [45], 
and it was proposed that this might be due to its interaction with ERp44, an ER-resident 
protein which inhibits the IP3R1 by binding to it in a redox-sensitive manner, such that 
oxidation of cysteine residues on the intraluminal LV3 domain of the IP3R1 prevents binding 
and therefore enhances channel opening [52]. We speculate that such a mechanism could 
provide a feasible explanation for how the non-localised production of hydroxyl anion 
26 
 
within the cytoplasm might result in a localised and reversible effect on signal transduction, 
in this case an increase in Ca2+ release.  
 
Although CP94 profoundly inhibited carbachol-induced endothelial Ca2+ release, the cell 
impermeant CP85 and DFO had no effect (Fig. 6A). In the presence of extracellular Ca2+, 
however, all the chelators reduced the response, which indicates that the hydroxyl radical 
formed outside the cell membrane is involved in the opening of the KCa channels (Fig. 6B & 
6C), which is evidence for H2O2 crossing the plasmalemma.  There is evidence that several 
ROS-sensitive Ca2+ - permeable channels, including TRPC3, TRPC4 and TRPM2, can 
contribute to Ca2+ influx in EC during the response to muscarinic agonists [27, 53]. Of these, 
to our knowledge a role for hydroxyl radical as a channel activator has only been reported 
for TRPM2, although this was shown to involve an action on intracellular cysteine residues 
[54].  
 
IL-1  and EDH 
The ability of IL-1  to promote EDH has not, to our knowledge, been reported previously, 
although it has been reported that this cytokine caused dilatation of new-born pig pial 
arterioles via a prostanoid- and cyclic nucleotide-dependent-mechanism [55]. The effects of 
IL-1  were prevented when it was co-applied with the NADPH-oxidase assembly inhibitor 
apocynin and the PKC blocker Ro31-8220, consistent with previous evidence that Il-1  
activates increases superoxide production and activates NADPH oxidase in EC [23, 56, 57]. 
The effect of IL-1  on the carbachol-induced EDHR in cremaster arterioles demonstrated 
several parallels with its effect on the bradykinin-induced permeability increase of rat pial 
venules described by Woodfin et al. [23] including a similar rapid induction and a sensitivity 
to ROS scavenging, apocynin and PKC blockade, and we speculate that activation of NADPH 
oxidase may constitute a widespread mechanism by which IL-1  can acutely regulate EC 
[Ca2+]i in the vascular endothelium, and may be one of the factors that are involved in septic 
shock. 
 
Conclusions  
We speculate that arteries/arterioles may fall into three categories with regard to the 
involvement of H2O2 in EDH. In one group, as evidenced by the lack of effect of catalase, 
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H2O2 is probably not involved in this response [4], although such a role has not been 
exhaustively examined for every stimulus which triggers EDH in these preparations. In 
another group, which notably includes coronary arteries, H2O2 itself seems to act as an 
important EDHF [6, 7, 10, 11]. The reports of Griffith and colleagues [19, 20] pointed to the 
existence of a third group of arteries in which H2O2 facilitates EDH, and focussed attention 
on IP3R-mediated Ca
2+ release in EC as its likely target. Our results now provide a more 
detailed picture of how H2O2 acts to promote EDH in the type of arteriole that falls into this 
category. We find that very small changes in the EC [H2O2] around the basal level can 
strongly modulate the EDHR via an effect on Ca2+ release. The data demonstrate that EDH 
triggered by muscarinic receptor activation is greatly facilitated by ROS which are produced 
when arachidonic acid synthesised by cPLA2 is metabolised by CYP450 2C9. A short pre-
treatment with IL-1  is able to further enhance carbachol-induced EDH. An increase in EC 
Ca2+ release, which would be expected to potentiate SOCE, and thereby also facilitate EC 
Ca2+ influx, is implicated in these responses. The effects of CP94 and CP85 indicate that 
hydroxyl radical plays an important role in this facilitation of Ca2+ release, and also 
demonstrate that ROS also promote EC Ca2+ influx during EDH.  
 
A limitation of our results is that we could not to record changes in [ROS] in the 
endothelium of these arterioles, possibly because these were very small. We were therefore 
unable to determine whether muscarinic receptor activation was increasing EC [ROS], or 
whether basal ROS levels were sufficient to facilitate Ca2+ release. PLA2 has, however, been 
shown to be activated by increases in EC [Ca2+]i, (e.g. 58) so that it is plausible that PLA2-
dependent ROS production would occur upon the application of carbachol.  
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Supplementary Figure 1.  Effects of CYP2C9 inhibitors on carbachol-induced responses 
(A) Effects of sulfaphenazole (10 M), PPOH (10 M) and ODYA (50 M) on the carbachol 
induced rise in EC [Ca2+]i and (B) the associated carbachol-induced vasodilation (n=5 for each 
condition). (C) These inhibitors were also tested on the carbachol-induced rise in endothelial 
[Ca2+]i in Ca
2+-free PSS containing 0.2 mM EGTA. All paired these were paired experiments 
with 5 to 8 vessels, one animal each; p<0.05 indicated by asterisks.  
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Supplementary Figure 2. Lack of a role for EETs in carbachol-induced EDH. 
(A) Application of 11,12 EET (1 µM) resulted in a profound vasodilatation, but (B) neither the 
EETs receptor blocker, EEZE (10 M), nor the inhibitor of the enzyme that catabolises EETs, 
AUDA (10 M), affected the carbachol-induced vasodilatation (right) or the rise in 
endothelial [Ca2+]i (left). 5 vessels from 5 animals; p<0.001 indicated by ***. 
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Supplementary Figure 3. Inhibition of several ROS-generating enzymes had no effect on 
responses to carbachol. 
There was no effect when allopurinol (100 µM), apocynin (1 µM), rotenone (10 µM) and NDGA (50 
µM) were used to block xanthine oxidase, NADPH oxidase, mitochondrial complex I and 
lipoxygenases respectively, on the carbachol-induced rise in (A) the calcium or (B) on the carbachol-
induced vasodilation.  Normal calcium-containing PSS on 5 vessels from 5 animals for each condition.  
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Graphical Abstract 
 
 
 
 
Highlights 
 
 We recorded carbachol- evoked endothelial cell (EC) [Ca2+]i rises in rat arterioles. 
 
 Ca2+ rises were reduced by catalase, cPLA2 and CYP29C blockers, and iron chelators. 
 
 EC Ca2+ release was potentiated by 30 pM IL-1  or M exogenous H2O2. 
 
 H2O2 and carbachol evoked vasodilation, but by dissimilar mechanisms. 
 
 H2O2 promotes hyperpolarization-dependent dilatation by increasing EC Ca
2+ release.  
 
 
 
 
